The Burrill Report
People with type 2 diabetes who are treated with long-term insulin therapy run the risk of developing a thickening of the retina that can lead to blindness. Now, researchers believe they may be able to prevent the condition that leads to the loss of vision in these patients with use of a drug that can prevent damage from occurring to the retinal nerve.
Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.
OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.
Learn more about writing for us